Lena Specht, MD, PhD
Rigshospitalet: University of Copenhagen: Employee
Merck Serono: Travel Expenses; MSD: Advisory Board; Takeda: Advisory Board, Consultant, Honoraria, Travel Expenses; Varian: Research Grants
Danish Hodgkin Lymphoma Group: Chairman; International Lymphoma Radiation Oncology Group: Vice President
Professor Lena Specht is Professor of Oncology at the University of Copenhagen, Denmark. She completed her training in Clinical Oncology at the University Hospital in Copenhagen. She held a research fellowship for three years at the Danish Cancer Society, and she obtained her PhD degree with work on prognostic factors in Hodgkin lymphoma.
Professor Specht is Chief Oncologist at the Department of Oncology at Rigshospitalet, University of Copenhagen. Her main areas of research and clinical interest are lymphomas and head & neck cancer. She is author of over 250 research articles and educational papers, including ILROG guidelines on lymphoma radiation therapy and ESMO guidelines on peripheral T-cell lymphomas and cutaneous lymphomas. She has authored two textbooks and numerous book chapters. She leads a Multidisciplinary Radiotherapy Research Group, comprising physicians, physicists, and civil engineers, and she has supervised 17 PhD projects and numerous post doc, postgraduate, and pregraduate projects. She is Editor of the Cochrane Haematological Malignancies Group and member of the Advisory Board for Acta Oncologica. She is Chairman of the Danish Hodgkin Lymphoma Group and Vice President of the International Lymphoma Radiation Oncology Group (ILROG). She has given over 100 invited lectures worldwide, and she is Course Director for the ESTRO-ILROG School Course on Haematological Malignancies.